Catalent, Inc. revised earnings guidance for the fiscal year 2022. For the year, the company expects net revenue in the range of $4.74 billion to $4.86 billion, representing growth of 19% to 22% versus previous estimate $4.62 billion to $4.82 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.36 USD | +0.64% | +1.24% | +25.73% |
07:42am | Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast | RE |
07:32am | Obesity drugmaker Novo Nordisk's Q1 profit beats forecast | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.73% | 10.13B | |
+29.87% | 699B | |
+25.07% | 571B | |
-4.46% | 364B | |
+18.34% | 326B | |
+3.19% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.56% | 154B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Catalent, Inc. revises Earnings Guidance for the Fiscal Year 2022